Tau Model Overview
For this Alzheimer's disease model, we perform stereotaxic inoculation of preformed fibrils (PFFs) into the hippocampus and overlying cerebral cortex of PS19 transgenic mice [B6;C3-Tg(Prnp-MAPT*P301S)PS19Vle/J]. These transgenic mice overexpress human tau with P301S mutation. The injection site was originally reported by Iba et al., J. Neurosci., 33: 1024-1037, 2013; doi: 10.1523/JNEUROSCI.2642-12.2013).
Tau Model Generation
A general schema for tau PFF animal model generation is:
We can also use human brain extracts/homogenates as a substitute for the recombinant fibrils in this model.
For this specific mouse model, we use PS19 male mice at 8 weeks-of-age. We then perform stereotaxic injection of sonicated, recombinant human tau PFFs or brain extracts into the hippocampus and overlying cortex.
We use digital stereotaxic devices with automated microinjectors for high accuracy & precision.
This animal model is highly reproducible with a nearly 100% success rate of tau PFF seeding.
Our Tau Mouse Model Validated Measures
- Body weight
- Clinical scores
- Neurofilament light chain (NfL; NF-L) measures in plasma & CSF
- Immunohistochemistry & multiplex immunofluorescence
Learn more about our characterization of this model, our validated measures, and our Preclinical Neuroscience CRO services.